Navigation Links
Canadian biomedical engineering pioneer receives international award
Date:4/23/2009

Countless individuals around the world are alive because of him. His 40 plus years of research have helped to make the use of life-saving devices such as prosthetic heart valves, vascular stents, vascular grafts, heart-assist devices, and heart-lung bypass systems almost commonplace. In the process, he has helped to establish Canada as a biomaterials leader.

John Brash, P.Eng., director of the School of Biomedical Engineering at McMaster University, and distinguished university professor, was recognized for these contributions with the presentation of the Founders Award by the Society for Biomaterials on April 22 in San Antonio, Texas.

"I am honoured and humbled to receive this award given the calibre of past recipients," said Prof. Brash. "It was a surprise when I was notified of the award. Much of the recognition must be shared with the numerous colleagues, peers, and students I have been fortunate to have worked with over the years."

Prof. Brash is only the second Canadian to receive this award, of which just 14 have been presented since it was established in 1987. Michael Sefton, university professor of chemical engineering and applied chemistry, University of Toronto, received the award in 2008. Selection for a Founders Award is based on long-term, landmark contributions to the discipline of biomaterials.

"John has been a leading member of the world's biomaterials community for many years," said Michael Sefton, past-president of the Society for Biomaterials and chair of the awards committee. "His seminal contributions to our understanding of the behaviour of proteins at interfaces and to the use of polyurethanes in medicine have been among the most important and long-standing contributions to the science of biomaterials."

Prof. Brash is internationally regarded for his work in at least three major areas: protein adsorption and blood compatibility, particularly as it relates to blood proteins and thrombus formation on artificial surfaces; biocompatible polyurethane based materials; and surface modification.

"His literature contributions have guided the work of countless biomaterials scientists," said Heather Sheardown, associate professor of chemical engineering at McMaster. "Another of John's important contributions is in the training of a new generation of biomaterials scientists who have gone on to work in academia and industry, continuing to advance the field and carrying with them a passion ignited during their time in the Brash lab."

Prof. Brash has trained some 50 Masters, PhDs and postdoctoral fellows. He is also called on to consult with numerous biomaterials-related companies.

"Dr. Brash, whether interacting with fellow chemical engineers, biomaterials scientists or clinicians, has had a significant influence on the evolution of the field of biomaterials," said Stuart Cooper, professor and chair of the department of chemical and biomolecular engineering, at Ohio State University.

Discoveries by Prof. Brash can be found in some of Canada's most successful biomedical companies including Interface Biologics Inc. of Toronto and Angiotech Inc. in Vancouver.

"The latter part of the 80s and early 90s ushered in the concept of designing biomaterials that were pro-active in their interaction with proteins and cells," explains Prof. Santerre, who is also chief scientific officer and co-founder of Interface Biologics. "John's program in polyurethane research was among the first to build-in functional monomers that would capitalize on simulating the natural mechanisms of anti-coagulant function. Today, the bioactive concept is revolutionizing medical devices by merging the biopharmaceutical field and medical device sector to deliver implant therapies that accelerate healing associated with serious diseases."


'/>"/>

Contact: Gene Nakonechny
genen@mcmaster.ca
905-525-9140 x26781
McMaster University
Source:Eurekalert

Related biology news :

1. Ancient organisms discovered in Canadian gold mine
2. Canadian Society of Exercise Physiology Annual Scientific Conference
3. Massive Canadian oilfield could be exploited using new UK system
4. First images from medical beamline at Canadian Light Source
5. Canadian scientist mines drugs database for new diabetes treatment
6. Fossil evidence of missing link in the origin of seals, sea lions, walruses found in Canadian Arctic
7. Boston University biomedical engineers find chink in bacterias armor
8. $22 million gift from Alfred Taubman launches new biomedical research institute
9. USC biomedical team to participate in $6 million low vision project
10. Phase 2 of Singapores Biomedical Sciences Initiative gains momentum for clinical research
11. UVa biomedical engineering study shows magnetic field can reduce swelling
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 2017 Research and Markets has announced the ... & Trends - Industry Forecast to 2025" report to their ... The Global ... CAGR of around 15.1% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
(Date:3/23/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Vehicle Anti-Theft System ... over the next decade to reach approximately $14.21 billion by 2025. ... forecasts for all the given segments on global as well as ...
(Date:3/22/2017)... Optimove , provider of the ... as 1-800-Flowers and AdoreMe, today announced two new ... Using Optimove,s machine learning algorithms, these features allow ... recommendations to their customers based not just on ... intent drawn from a complex web of data ...
Breaking Biology News(10 mins):
(Date:7/26/2017)... Grand Bahama (PRWEB) , ... July 26, 2017 , ... ... Regenerative Medicine , which is licensed by the Bahamas’ National Stem Cell Ethics Committee ... (MBBS) from the University of the West Indies. He went on to complete residency ...
(Date:7/26/2017)... - Caprion Biosciences Inc., a world leading specialty CRO announced the ... of early stage (latent) Mycobacterium tuberculosis (Mtb) infection using state-of-the-art ... platform. ... Caprion Biosciences Inc. (CNW Group/Caprion Biosciences) ... The new data, recently published in ...
(Date:7/26/2017)... ... July 25, 2017 , ... The leading Regenerative Veterinary Medicine ... cell therapy has been used on more than 13,000 animals. VetStem was ... fatal injuries to tendons and ligaments. , In 2003 VetStem signed a worldwide ...
(Date:7/26/2017)... ... July 26, 2017 , ... Spectral ... we face every day. This unique capability combines high resolution imaging with ... manufacturers to deliver unprecedented datasets for chemical analysis, quality control, and decision-making. , ...
Breaking Biology Technology: